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Background 
The impact of biofilm in the effective control 
of wound microbiome is an ongoing dilemma 
which has seen the use of different 
treatment strategies. The effects of wound 
dressings and antibiotics on both planktonic 
bacteria and biofilms have been separately 
evaluated in previous studies.1,2,3,4 Some of 
the methods used include 96-well microtitre 
plate assay, 6-well plate assay, isothermal 
calorimetry, microscopy and the constant 
depth film fermentation.1,2,5,7,9   
However, the quest for a more sensitive and 
reproducible method to mimic the biofilm 
phenotype is ongoing. One such method 
uses poloxamer gel to grow biofilm 
phenotype due to its proven ability to 
promote sessile growth and maintain the 
biofilm architecture to mimic clinically 
conditions.8  
 
Aim of Study 
The aim of this study was to assess the 
combined effects of some selected wound 
dressings (silver-impregnated: Acticoat 
(ACT) and Silvercel (SIL); and  honey-
impregnated: Medihoney™ Apinate (MA)) 
and antibiotics (ceftazdime and levofloxacin) 
on Klebsiella pneumoniae and Proteus 
mirabilis biofilms using a standard agar 
assay.  The ability of poloxamer gel cultures 
to support sessile growth and maintain 
biofilm architecture was also assessed in 
comparison with the standard agar method. 
 
Methods 
The two multidrug resistant diabetic foot 
isolates  were initially grown overnight and 
diluted to final broth suspensions of 108 
colony forming unit (CFU)/mL.5 1 mL 
volumes of K. pneumoniae and P. mirabilis 
suspensions containing ceftazidime (CAZ) 
and levofloxacin (LEV) at final 
concentrations of 256, 512, 1024 and 5120 
µg/mL were inoculated on Mueller Hinton 
agar (MHA) and 30% (w/v) Kolliphor® P 407 
(poloxamer) gel plates and allowed to dry. 
Wound dressings cut into circular shapes 
(2cm-diameter) were aseptically placed on 
the agar and gel plates and incubated at 35 
– 37°C for 24 hours. ZOIs produced by the 
3 antibacterial dressings after 24 hours were 
measured and compared with a control 
dressing (Atrauman (ATR) – with no 
antibacterial activity). 
The ZOIs measurements are presented as 
means (±SEM) and statistically analyzed 
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Results 
ZOIs associated with ACT, SIL and MA 
dressings augmented with CAZ and LEV 
were compared with no antibiotic that of ATR  
controls. All three dressings showed 
significant (p < 0.05) biofilm-inhibiting 
activity against both bacteria at antibiotic 
concentrations of 1024 and 5120µg/mL with 
ZOI between 17.5 and 35mm on MHA 
(Figure 2. (A) and (B)). Similarly, significant 
ZOIs on Kolliphor® P 407 gels were 
between 22 and 30mm at the same 
concentrations (Figure 2. (C) and (D)).  
 
Discussion 
This study has demonstrated that clinical 
strains of K. pneumoniae and P. mirabilis 
biofilms are highly resistant to current 
antimicrobial agents on the market. They are 
however sensitive to higher concentrations 
of antibiotics which are not clinically 
applicable. 
In this study, ACT produced greater ZOIs 
against both K. pneumoniae and P. mirabilis  
biofilms than SIL and MA. This suggests that 
the continuous treatment of infected diabetic 
foot with ACT can improve healing.  
It was also observed that, all 3 dressings 
were less effective on Kolliphor-grown 
biofilms than on MHA. This is because 
standard agar only promotes the growth of 
colony forming units in a semi-sessile state 
as previously described.10 
As already established and confirmed in this 
study, biofilms are difficult to treat.5,6 Their 
presence in wounds prolong healing, 
increase cost of treatment and affect the 
quality of life of affected individuals. 
Therefore, the effective management of 
chronic wounds must encompass a holistic 
approach that includes antimicrobial 
chemotherapy, surgical debridement, 
physiotherapy and periodic reviews. 
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Figure. 2. Effect of wound dressings in combination with 
antibiotics on (A). K. pneumoniae and (B).  P. mirabilis biofilm (*) - 
shows significant inhibition of biofilms on MHA (p < 0.05). 
Figure. 2. Effect of wound dressings in combination with antibiotics 
on (C). K. pneumoniae and (D). P. mirabilis biofilms. (*) - shows 
significant inhibition of biofilms on Kolliphor gel (p < 0.05) 
Figure. 1. P. mirabilis  biofilm phenotypes with ZOI on (A). Kolliphor gel 
and (B). MHA 
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